New research into the dying brain suggests the line between life and death may be less distinct than previously thought.
Read morePsychedelics, Psychosis and Manic Symptoms
In the twin data researchers reviewed, mania was also strongly correlated with a genetic predisposition to schizophrenia and to bipolar I disorder.
In other words, those who experienced manic symptoms after psychedelic use may have been more genetically prone to mental illnesses.
Read moreVideo: The Global Psychedelic Survey, Primary Outcomes
Psilocybin for Anxiety
Also the trial’s rate of full remission, or a full cessation of symptoms, was five times greater than the placebo group, a marked and compelling difference in treatment outcomes.
Read moreThe Benefits of Psilocybin
Small clinical trials have shown that one or two doses of psilocybin, given in a therapeutic setting, can make dramatic and long-lasting changes in people suffering from treatment-resistant major depressive disorder, which typically does not respond to traditional antidepressants.
Click here for the link to this article.
Read moreMDMA, Trauma, Addictions and Psychedelics
Dr. Ben Sessa discusses his latest research here.
Psychedelics, Research and the Brain
VA to Fund Studies on Psychedelics for Mental Health
The Department of Veterans Affairs issued a request for applications (RFA) for proposals from its network of VA researchers (in collaboration with academic institutions) to study the use of certain psychedelic compounds in treating posttraumatic stress disorder (PTSD) and depression.
Read morePotential Risk Factors for Bad Trips
New research has found that stressful or unsafe environments, negative expectations and a lack of social support during and after the psychedelic experience were all associated with negative outcomes when taking psychedelics.
Read morePsychedelics and Chronic Pain
This research article looks at some preliminary clinical findings that suggest potential efficacy of psychedelics for chronic pain, and the need for further research.
Read morePodcast: Metaplasticity and Reopening Critical Periods with Psychedelics
This podcast discusses how psychedelics reopen critical periods of learning, and how the true benefit of psychedelics could be in learning how best to reopen those critical periods, how long they’re open for, and which therapeutic frameworks and integration practices could best take advantage of them.
Read more